A detailed history of Wells Fargo & Company transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 13,999 shares of STTK stock, worth $17,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,999
Previous 14,061 0.44%
Holding current value
$17,358
Previous $54,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.0 - $4.85 $186 - $300
-62 Reduced 0.44%
13,999 $48,000
Q2 2024

Aug 13, 2024

BUY
$3.56 - $11.18 $48,864 - $153,456
13,726 Added 4097.31%
14,061 $54,000
Q1 2024

May 10, 2024

BUY
$7.37 - $10.09 $420 - $575
57 Added 20.5%
335 $2,000
Q4 2023

Feb 09, 2024

BUY
$1.37 - $7.24 $20 - $108
15 Added 5.7%
278 $1,000
Q3 2023

Nov 13, 2023

SELL
$1.42 - $3.16 $15,455 - $34,393
-10,884 Reduced 97.64%
263 $0
Q2 2023

Aug 15, 2023

BUY
$2.52 - $3.66 $27 - $40
11 Added 0.1%
11,147 $34,000
Q1 2023

May 12, 2023

BUY
$2.5 - $4.72 $7 - $14
3 Added 0.03%
11,136 $32,000
Q4 2022

Feb 13, 2023

BUY
$1.96 - $3.26 $13 - $22
7 Added 0.06%
11,133 $25,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.52 $119 - $253
46 Added 0.42%
11,126 $30,000
Q2 2022

Aug 12, 2022

SELL
$2.7 - $4.59 $4,814 - $8,183
-1,783 Reduced 13.86%
11,080 $45,000
Q1 2022

May 16, 2022

SELL
$4.22 - $8.89 $39,874 - $84,001
-9,449 Reduced 42.35%
12,863 $55,000
Q4 2021

Feb 14, 2022

SELL
$8.36 - $21.08 $53,336 - $134,490
-6,380 Reduced 22.24%
22,312 $189,000
Q3 2021

Nov 15, 2021

BUY
$17.57 - $28.95 $500,973 - $825,451
28,513 Added 15929.05%
28,692 $584,000
Q2 2021

Aug 16, 2021

SELL
$24.14 - $37.68 $55,353 - $86,400
-2,293 Reduced 92.76%
179 $5,000
Q1 2021

May 13, 2021

SELL
$27.92 - $52.5 $120,893 - $227,325
-4,330 Reduced 63.66%
2,472 $73,000
Q4 2020

Feb 09, 2021

BUY
$19.0 - $57.61 $129,238 - $391,863
6,802 New
6,802 $356,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $52.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.